Viewing Study NCT01110902


Ignite Creation Date: 2025-12-25 @ 4:04 AM
Ignite Modification Date: 2026-03-08 @ 1:55 AM
Study NCT ID: NCT01110902
Status: COMPLETED
Last Update Posted: 2020-12-24
First Post: 2010-04-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD)
Sponsor: Novartis Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CAGO178C2302
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators